{
    "clinical_study": {
        "@rank": "139428", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention"
            }, 
            {
                "arm_group_label": "PD patients without sleep problems", 
                "arm_group_type": "No Intervention"
            }, 
            {
                "arm_group_label": "PD patients with sleep problems", 
                "arm_group_type": "Active Comparator", 
                "description": "light exposure"
            }, 
            {
                "arm_group_label": "PD patients with sleep problem", 
                "arm_group_type": "Placebo Comparator", 
                "description": "light exposure"
            }
        ], 
        "brief_summary": {
            "textblock": "Disruption of sleep and alertness is one of the most disabling non-motor symptoms of\n      Parkinson's disease (PD). Mechanisms leading to impaired sleep and alertness in PD are not\n      well understood, and treatment options remain limited. The proposed research will examine\n      markers of the circadian system, sleepiness and sleep quality in PD patients and healthy\n      controls. Further, the project will examine effects of bright light exposure on circadin\n      function, sleep and alertness in PD."
        }, 
        "brief_title": "Circadian Rhythms and Sleep-Wake Cycles in Parkinson's Disease", 
        "completion_date": {
            "#text": "May 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Parkinson's Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Diagnosis of idiopathic PD as defined by the United Kingdom PD Society Brain Bank\n             Criteria;\n\n          2. PD Hoehn and Yahr stage 2-4;\n\n          3. Pittsburgh Sleep Quality Index (PSQI) score >5 in group 1, and \u22645 in group 2;\n\n          4. Epworth Sleepiness Scale (ESS) score \u226510 in group 1, and <10 in group 2;\n\n        Control participants will be matched for gender and age with PD participants.\n\n        Exclusion Criteria:\n\n          1. Atypical or secondary forms of Parkinsonism;\n\n          2. Cognitive impairment as determined by the Mini-Mental State Examination (MMSE) score\n             of \u2264 26;\n\n          3. Presence of depression defined as the Beck Depression Inventory (BDI) score >14;\n\n          4. Use of hypno-sedative drugs for sleep or stimulants; participants will be allowed to\n             taper these drugs and will become eligible at least 4 weeks after the taper is\n             completed;\n\n          5. Use of SSRIs / SNRIs antidepressants, unless the participant has been on a stable\n             dose for at least 3 months prior to the screening;\n\n          6. Use of medications known to affect melatonin secretion;\n\n          7. Unstable/serious medical illness."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "85 Years", 
            "minimum_age": "55 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01742182", 
            "org_study_id": "Circadian Rhythms in PD", 
            "secondary_id": "1K23NS072283-01A1"
        }, 
        "intervention": {
            "arm_group_label": [
                "PD patients with sleep problems", 
                "PD patients with sleep problem"
            ], 
            "intervention_name": "Light exposure", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Parkinson's Disease", 
            "Excessive Daytime Sleepiness", 
            "Circadian Rhythms", 
            "Light Therapy"
        ], 
        "lastchanged_date": "December 5, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60611"
                }, 
                "name": "Northwestern University"
            }, 
            "investigator": {
                "last_name": "Aleksandar Videnovic, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Circadian Rhythms and Sleep-Wake Cycles in Parkinson's Disease", 
        "overall_contact": {
            "email": "l-wulf@northwestern.edu", 
            "last_name": "Laura Wulf, MA", 
            "phone": "312-503-1999"
        }, 
        "overall_contact_backup": {
            "email": "k-williams8@northwestern.edu", 
            "last_name": "Karen Williams, BA", 
            "phone": "312-503-5645"
        }, 
        "overall_official": {
            "affiliation": "Northwestern University", 
            "last_name": "Aleksandar Videnovic, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board, Northwestern University", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "circadian rhythm of melatonin", 
                "safety_issue": "No", 
                "time_frame": "June 2012- May 2017"
            }, 
            {
                "measure": "Sleep Efficiency", 
                "safety_issue": "No", 
                "time_frame": "June 2012- May 2017"
            }, 
            {
                "measure": "Daytime Somnolence", 
                "safety_issue": "No", 
                "time_frame": "June 2012- May 2017"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01742182"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Northwestern University", 
            "investigator_full_name": "Aleksandar Videnovic", 
            "investigator_title": "Assistant Professor of Neurology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Northwestern University", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute of Neurological Disorders and Stroke (NINDS)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Northwestern University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}